Literature DB >> 19871543

HEMOGLOBIN AND PLASMA PROTEIN PRODUCTION : VARIOUS PROTEINS, CONCENTRATES, AND DIGESTS INFLUENCE BLOOD PROTEIN PRODUCTION IN ANEMIA AND HYPOPROTEINEMIA.

F S Robscheit-Robbins1, L L Miller, G H Whipple.   

Abstract

Given healthy dogs, fed abundant iron and protein-free or low protein diets, with sustained anemia and hypoproteinemia due to bleeding, we can study the capacity of these animals to produce simultaneousiy new hemoglobin and plasma protein. The reserve stores of blood protein-producing materials in this way are largely depleted, and levels of 6 to 8 gm. per cent for hemoglobin and 4 to 5 gm. per cent for plasma protein can be maintained for considerable periods of time. These dogs are very susceptible to infection and to injury by many poisons. Dogs tire of these diets and loss of appetite terminates many experiments. These incomplete experiments are not recorded in the present paper but give supporting evidence in harmony with those tabulated. Under these conditions (double depletion) the dogs use effectively the proteins listed above-egg, lactalbumin, meat, beef plasma, and digests of various food proteins and hemoglobin. Egg protein at times seems to favor slightly the production of plasma protein when compared with the average response (Tables 1 and 2). Various digests and concentrates compare favorably with good food proteins in the production of new hemoglobin and plasma protein in these doubly depleted dogs. Whole beef plasma by mouth is well utilized and the production of new hemoglobin is, if anything, above the average-certainly plasma protein production is not especially favored. "Modified" beef plasma by vein causes fatal anaphylaxis (Table 4). Hemoglobin digests are well used by mouth to form both hemoglobin and plasma protein. Supplementation by amino acids is recorded. Methionine in one experiment may have been responsible for a better protein output and digest utilization (Table 7).

Entities:  

Year:  1946        PMID: 19871543      PMCID: PMC2135589     

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  HEMOGLOBIN AND PLASMA PROTEIN : SIMULTANEOUS PRODUCTION DURING CONTINUED BLEEDING AS INFLUENCED BY DIET PROTEIN AND OTHER FACTORS.

Authors:  F S Robscheit-Robbins; S C Madden; A P Rowe; A P Turner; G H Whipple
Journal:  J Exp Med       Date:  1940-10-31       Impact factor: 14.307

2.  HEMOGLOBIN AND PLASMA PROTEIN : THEIR RELATION TO INTERNAL BODY PROTEIN METABOLISM.

Authors:  L L Miller; F S Robscheit-Robbins; G H Whipple
Journal:  J Exp Med       Date:  1945-05-01       Impact factor: 14.307

3.  PLASMA PROTEIN METABOLISM-NORMAL AND ASSOCIATED WITH SHOCK : OBSERVATIONS USING PROTEIN LABELED BY HEAVY NITROGEN IN LYSINE.

Authors:  R M Fink; T Enns; C P Kimball; H E Silberstein; W F Bale; S C Madden; G H Whipple
Journal:  J Exp Med       Date:  1944-12-01       Impact factor: 14.307

4.  HEMOGLOBIN AND PLASMA PROTEIN : SIMULTANEOUS PRODUCTION DURING CONTINUED BLEEDING AS INFLUENCED BY AMINO ACIDS, PLASMA, HEMOGLOBIN, AND DIGESTS OF SERUM, HEMOGLOBIN, AND CASEIN.

Authors:  F S Robscheit-Robbins; L L Miller; G H Whipple
Journal:  J Exp Med       Date:  1943-04-01       Impact factor: 14.307

  4 in total
  3 in total

1.  PLASMA PROTEIN AND HEMOGLOBIN PRODUCTION : DELETION OF INDIVIDUAL AMINO ACIDS FROM GROWTH MIXTURE OF TEN ESSENTIAL AMINO ACIDS. SIGNIFICANT CHANGES IN URINARY NITROGEN.

Authors:  F S Robscheit-Robbins; L L Miller; G H Whipple
Journal:  J Exp Med       Date:  1947-02-28       Impact factor: 14.307

2.  Dietary effects on anemia plus hypoproteinemia in dogs; some proteins further the production of hemoglobin and others plasma protein production.

Authors:  F S ROBSCHEIT-ROBBINS; G H WHIPPLE
Journal:  J Exp Med       Date:  1949-03       Impact factor: 14.307

3.  ANEMIA AND HYPOPROTEINEMIA : WEIGHT MAINTENANCE EFFECTED BY FOOD PROTEINS BUT NOT BY MIXTURES OF PURE AMINO ACIDS.

Authors:  L L Miller; F S Robscheit-Robbins; G H Whipple
Journal:  J Exp Med       Date:  1947-02-28       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.